To explore the potential impact of albumin therapy on the development of SA-AKI in patients suffering from sepsis, the present study will employ a target trial emulation (TTE) approach to simulate an ideal randomized controlled trial (RCT). The gene discussed is ALB; the disease is acute kidney injury.